Genetic analysis of LRRK2 P755L variant in Caucasian patients with Parkinson's disease

Neuroscience Letters

Volumn 419, Issue 2, 2007, Pages 104-107

  Deng, Hao ^a   Le, Weidong ^a   Huang, Maosheng ^b   Xie, Wenjie ^a   Pan, Tianghong ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Caucasian; P755L; Parkinson's disease; The leucine rich repeat kinase 2 gene; Variant

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ESSENTIAL TREMOR; EXON; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL;

AGED; BRAIN; BRAIN CHEMISTRY; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; PROTEIN-SERINE-THREONINE KINASES;

EID: 34248203138     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.04.026     Document Type: Article

References (18)

1. Berg D., Schweitzer K., Leitner P., Zimprich A., Lichtner P., Belcredi P., Brussel T., Schulte C., Maass S., and Nagele T. Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease. Brain 128 (2005) 3000-3011
2. Deng H., Le W., Davidson A.L., Xie W., and Jankovic J. The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor. Neurosci. Lett. 407 (2006) 97-100
3. Deng H., Le W., Guo Y., Hunter C.B., Xie W., Huang M., and Jankovic J. Genetic analysis of LRRK2 mutations in patients with Parkinson disease. J. Neurol. Sci. 251 (2006) 102-106
4. Deng H., Le W., Guo Y., Hunter C.B., Xie W., and Jankovic J. Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation. Ann. Neurol. 57 (2005) 933-934
5. Deng H., Le W., and Jankovic J. Premutation alleles associated with Parkinson disease and essential tremor. JAMA 292 (2004) 1685-1686
6. Deng H., Le W.D., Xie W.J., Pan T.H., Zhang X., and Jankovic J. Genetic analysis of parkin co-regulated gene (PACRG) in patients with early-onset parkinsonism. Neurosci. Lett. 382 (2005) 297-299
7. Deng H., Xie W., Guo Y., Le W., and Jankovic J. Gene dosage analysis of alpha-synuclein (SNCA) in patients with Parkinson's disease. Mov. Disord. 21 (2006) 728-729
8. Di Fonzo A., Wu-Chou Y.H., Lu C.S., van Doeselaar M., Simons E.J., Rohe C.F., Chang H.C., Chen R.S., Weng Y.H., Vanacore N., Breedveld G.J., Oostra B.A., and Bonifati V. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 7 (2006) 133-138
9. Gelb D.J., Oliver E., and Gilman S. Diagnostic criteria for Parkinson's disease. Arch. Neurol. 56 (1999) 33-39
10. Lesage S., Durr A., Tazir M., Lohmann E., Leutenegger A.L., Janin S., Pollak P., Brice A.B., and French Parkinson's Disease Genetics Study Group. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N. Engl. J. Med. 354 (2006) 422-423
11. Mata I.F., Wedemeyer W.J., Farrer M.J., Taylor J.P., and Gallo K.A. LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci. 29 (2006) 286-293
12. Ozelius L.J., Senthil G., Saunders-Pullman R., Ohmann E., Deligtisch A., Tagliati M., Hunt A.L., Klein C., Henick B., Hailpern S.M., Lipton R.B., Soto-Valencia J., Risch N., and Bressman S.B. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 354 (2006) 424-425
13. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., Lopez de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Marti-Masso J.F., Perez-Tur J., Wood N.W., and Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004) 595-600
14. Pankratz N., Pauciulo M.W., Elsaesser V.E., Marek D.K., Halter C.A., Rudolph A., Shults C.W., Foroud T., Nichols W.C., and Parkinson Study Group-PROGENI Investigators. Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease. Mov. Disord. 21 (2006) 2257-2260
15. Shahed J., and Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat. Disord. 13 (2007) 67-76
16. Tan E.K., Skipper L., Chua E., Wong M.C., Pavanni R., Bonnard C., Kolatkar P., and Liu J.J. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease. Mov. Disord. 21 (2006) 997-1001
17. Wu T., Zeng Y., Ding X., Li X., Li W., Dong H., Chen S., Zhang X., Ma G., Yao J., and Deng X. A novel P755L mutation in LRRK2 gene associated with Parkinson's disease. Neuroreport 17 (2006) 1859-1862
18. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Muller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolek Z.K., and Gasser T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44 (2004) 601-607